H.RES. 242: AFFIRMING THE IMPORTANCE OF THE ORPHAN DRUG ACT, CELEBRATING THE OVER 750 NEW ORPHAN THERAPIES APPROVED SINCE ITS CREATION, AND RECOGNIZING THE NEED TO CONTINUE SUPPORTING RESEARCH AND DEVELOPMENT FOR RARE DISEASE; ALL PROVISIONS OF THE RESOLUTION

H.R. 1046: MEDICARE NEGOTIATION AND COMPETITIVE LICENSING ACT OF 2019; ALL PROVISION OF THE BILL

S. 377:  MEDICARE NEGOTIATION AND COMPETITIVE LICENSING ACT OF 2019; ALL PROVISION OF THE BILL

GENERAL DISCUSSIONS REGARDING GENE THERAPY AND VALUE BASED CONTRACTING

GENERAL DISCUSSIONS REGARDING NEWBORN SCREENING RE-AUTHORIZATION ACT 

GENERAL DISCUSSIONS REGARDING THE ORPHAN DRUG ACT

GENERAL DISCUSSIONS REGARDING HEALTH CARE FINANCING H.R. 1046: MEDICARE NEGOTIATION AND COMPETITIVE LICENSING ACT OF 2019; ALL PROVISION OF THE BILL 

S. 377: MEDICARE NEGOTIATION AND COMPETITIVE LICENSING ACT OF 2019; ALL PROVISION OF THE BILL

GENERAL DISCUSSIONS REGARDING GENE THERAPY AND VALUE BASED CONTRACTING
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMARIN PHARMACEUTICAL INC.
770 Lindaro Street, San Rafael, CA, 94901, US
KATHRYN LOWELL (N/A) TERICKE BLANCHARD (N/A) JOHN EDWARD GREISSING (N/A) JOHN EDWARD GREISSING (N/A)
N/A N/A N/A N/A